1. Home
  2. PRTA vs DJCO Comparison

PRTA vs DJCO Comparison

Compare PRTA & DJCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • DJCO
  • Stock Information
  • Founded
  • PRTA 2012
  • DJCO 1987
  • Country
  • PRTA Ireland
  • DJCO United States
  • Employees
  • PRTA N/A
  • DJCO N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • DJCO Newspapers/Magazines
  • Sector
  • PRTA Health Care
  • DJCO Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • DJCO Nasdaq
  • Market Cap
  • PRTA 809.8M
  • DJCO 793.7M
  • IPO Year
  • PRTA N/A
  • DJCO N/A
  • Fundamental
  • Price
  • PRTA $9.20
  • DJCO $377.40
  • Analyst Decision
  • PRTA Buy
  • DJCO
  • Analyst Count
  • PRTA 9
  • DJCO 0
  • Target Price
  • PRTA $54.57
  • DJCO N/A
  • AVG Volume (30 Days)
  • PRTA 557.1K
  • DJCO 9.2K
  • Earning Date
  • PRTA 05-07-2025
  • DJCO 05-13-2025
  • Dividend Yield
  • PRTA N/A
  • DJCO N/A
  • EPS Growth
  • PRTA N/A
  • DJCO 370.42
  • EPS
  • PRTA N/A
  • DJCO 55.48
  • Revenue
  • PRTA $135,157,000.00
  • DJCO $71,642,000.00
  • Revenue This Year
  • PRTA N/A
  • DJCO N/A
  • Revenue Next Year
  • PRTA $131.71
  • DJCO N/A
  • P/E Ratio
  • PRTA N/A
  • DJCO $6.89
  • Revenue Growth
  • PRTA 47.92
  • DJCO 0.34
  • 52 Week Low
  • PRTA $9.10
  • DJCO $333.29
  • 52 Week High
  • PRTA $25.42
  • DJCO $602.00
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 26.58
  • DJCO 44.76
  • Support Level
  • PRTA $9.30
  • DJCO $359.34
  • Resistance Level
  • PRTA $10.45
  • DJCO $392.76
  • Average True Range (ATR)
  • PRTA 0.81
  • DJCO 16.45
  • MACD
  • PRTA -0.15
  • DJCO 0.32
  • Stochastic Oscillator
  • PRTA 2.77
  • DJCO 31.99

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About DJCO Daily Journal Corp. (S.C.)

Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Journal Technologies segment.

Share on Social Networks: